Can Awiqli Help Novo Nordisk Build a New Growth Engine Beyond GLP-1s? – August 20, 2026
Key Takeaways Novo Nordisk launched Awiqli, the first once-weekly basal insulin for adults with T2D in the United…
Can Novo Nordisk’s GLP-1 Pill Momentum Offset LLY’s Growing Edge? – August 13, 2026
Key Takeaways Novo Nordisk’s oral GLP-1s gained traction, but LLY’s injectable portfolio continued to capture market share.Lilly’s Zepbound…
Novo Nordisk Dips 4% in a Month: How Should Investors Play the Stock? – August 12, 2026
Key Takeaways NVO stock fell 4% in a month, as flat Wegovy sales raised concerns about its growth…
Bear of the Day: DSV (DSDVY) – August 4, 2026
The transportation and logistics market has experienced a volatile operating environment this year as geopolitical tensions, elevated energy…
Bear of the Day: DSV (DSDVY) – August 4, 2026
The transportation and logistics market has experienced a volatile operating environment this year as geopolitical tensions, elevated energy…
Novo Nordisk Before Q2 Earnings: How Should Investors Play the Stock? – August 3, 2026
Key Takeaways Novo Nordisk to report Q2 2026 results on Aug. 5, with the spotlight on Ozempic and…
Madonna brings out Kylie Minogue for duet at WorldPride Amsterdam – Music News
Madonna has surprised fans by bringing out Kylie Minogue for a special performance during WorldPride Amsterdam 2026. As…
Can Medicare Bridge Help Novo Nordisk Defend Its GLP-1 Leadership? – July 3, 2026
Key Takeaways Novo Nordisk’s Wegovy joins Medicare GLP-1 Bridge with a $50 monthly copay through the end of…
Novo Nordisk vs. Viking: Which Obesity Drug Stock Is the Better Buy? – June 29, 2026
Key Takeaways NVO and VKTX offer contrasting investment profiles, balancing market leadership with clinical-stage potential.Novo Nordisk pairs blockbuster…
Top Research Reports for Shell, Novo Nordisk & SAP – June 24, 2026
Wednesday, June 24, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today’s…
Can Pfizer Take Share From Lilly & Novo Nordisk in the Obesity Space? – June 18, 2026
Key Takeaways Pfizer acquired Metsera, adding berobenatide and other obesity programs with blockbuster potential.PFE plans more than 20…
Novo Nordisk Gains 7% in a Week: How Should Investors Play the Stock? – June 15, 2026
Key Takeaways NVO gained 7% in a week after the U.K. approval of oral Wegovy and favorable commercial…